{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:40:48Z","timestamp":1791272448288,"version":"4.1.0"},"reference-count":66,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["UM.C\/HIR\/MOHE\/MED\/16"],"award-info":[{"award-number":["UM.C\/HIR\/MOHE\/MED\/16"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2016.00609","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T16:50:30Z","timestamp":1461775830000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":56,"title":["Evaluation of Immunoprotection Conferred by the Subunit Vaccines of GRA2 and GRA5 against Acute Toxoplasmosis in BALB\/c Mice"],"prefix":"10.3389","volume":"7","author":[{"given":"Xiao T.","family":"Ching","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mun Y.","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee L.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,4,27]]},"reference":[{"issue":"87S","key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1550-7408.1997.tb05800.x","article-title":"Role of IFN-gamma, TNF-alpha, IL4 and IL10 in the regulation of experimental Toxoplasma gondii infection.","volume":"44","author":"Bessieres","year":"1997","journal-title":"J. Eukaryot. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1286-4579(03)00048-0","article-title":"Development of a vaccine for toxoplasmosis: current status.","volume":"5","author":"Bhopale","year":"2003","journal-title":"Microbes Infect."},{"key":"B3","first-page":"169","article-title":"Toxoplasmosis: advances and vaccine perspectives","author":"Bruna-Romero","year":"2012","journal-title":"Current Topics in Tropical Medicine"},{"key":"B4","first-page":"289","article-title":"Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances.","volume":"29","author":"Buxton","year":"1998","journal-title":"Vet Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0769-2625(88)90135-3","article-title":"Vaccination against parasitic diseases: some alternative concepts for the definition of protective antigens.","volume":"139","author":"Capron","year":"1988","journal-title":"Ann. Inst. Pasteur Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0923-2494(05)80096-3","article-title":"Excreted\/secreted antigens of Toxoplasma gondii\u2013their origin and role in the host-parasite interaction.","volume":"144","author":"Cesbron-Delauw","year":"1993","journal-title":"Res. Immunol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3347\/kjp.2001.39.3.233","article-title":"Effects of specific monoclonal antibodies to dense granular proteins on the invasion of Toxoplasma gondii in vitro and in vivo.","volume":"39","author":"Cha","year":"2001","journal-title":"Korean J. Parasitol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1631\/jzus.B0820300","article-title":"Protective effect of DNA-mediated immunization with liposome-encapsulated GRA4 against infection of Toxoplasma gondii.","volume":"10","author":"Chen","year":"2009","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"B9","first-page":"375","article-title":"Heterologous expression of Toxoplasma gondii dense granule protein 2 and 5.","volume":"46","author":"Ching","year":"2015","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"key":"B10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.11.4.569","article-title":"Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection.","volume":"11","author":"Denkers","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/0264-410X(92)90369-U","article-title":"Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant.","volume":"10","author":"Dillon","year":"1992","journal-title":"Vaccine"},{"key":"B12","first-page":"313","author":"Dubey","year":"2010","journal-title":"Toxoplasmosis of Animals and Humans"},{"key":"B13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.exppara.2009.06.002","article-title":"Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis.","volume":"123","author":"Dziadek","year":"2009","journal-title":"Exp. Parasitol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.exppara.2012.02.026","article-title":"Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2 ROP4 GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB\/c mice.","volume":"131","author":"Dziadek","year":"2012","journal-title":"Exp. Parasitol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1016\/j.vaccine.2006.02.039","article-title":"Potent antigen-specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using Rop2-Leishmania infantum Hsp83 fusion protein.","volume":"24","author":"Echeverria","year":"2006","journal-title":"Vaccine"},{"key":"B16","doi-asserted-by":"publisher","first-page":"11491","DOI":"10.1128\/JVI.76.22.11491-11504.2002","article-title":"Kaposi\u2019s sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis.","volume":"76","author":"Feng","year":"2002","journal-title":"J. Virol."},{"key":"B17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1128\/IAI.38.1.360-367.1982","article-title":"Toxoplasmosis in immunoglobulin M-suppressed mice.","volume":"38","author":"Frenkel","year":"1982","journal-title":"Infect. Immun."},{"key":"B18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.146.1.286","article-title":"Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine.","volume":"146","author":"Gazzinelli","year":"1991","journal-title":"J. Immunol."},{"key":"B19","doi-asserted-by":"crossref","first-page":"798","DOI":"10.4049\/jimmunol.157.2.798","article-title":"In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.","volume":"157","author":"Gazzinelli","year":"1996","journal-title":"J. Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/eji.1830250329","article-title":"Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo.","volume":"25","author":"Germann","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1016\/j.vaccine.2007.02.057","article-title":"Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.","volume":"25","author":"Golkar","year":"2007","journal-title":"Vaccine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/0020-7519(95)00103-4","article-title":"Toxoplasma gondii: the role of parasite surface and secreted proteins in host cell invasion.","volume":"26","author":"Grimwood","year":"1996","journal-title":"Int. J. Parasitol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.4049\/jimmunol.166.10.6041","article-title":"B cell immunodeficiency fails to develop in CD4-deficient mice infected with BM5: murine AIDS as a multistep disease.","volume":"166","author":"Harris","year":"2001","journal-title":"J. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1046\/j.1469-0691.2002.00485.x","article-title":"Toxoplasma gondii: transmission, diagnosis and prevention.","volume":"8","author":"Hill","year":"2002","journal-title":"Clin. Microbiol. Infect."},{"key":"B25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.vetpar.2010.11.047","article-title":"Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii.","volume":"177","author":"Hiszczynska-Sawicka","year":"2011","journal-title":"Vet. Parasitol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4238\/vol7-2gmr423","article-title":"Toxoplasma gondii: cloning, sequencing, expression, and antigenic characterization of ROP2 GRA5 and GRA7.","volume":"7","author":"Igarashi","year":"2008a","journal-title":"Genet. Mol. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.exppara.2007.10.002","article-title":"Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB\/c mice.","volume":"118","author":"Igarashi","year":"2008b","journal-title":"Exp. Parasitol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1586\/erv.10.113","article-title":"Vaccination against Toxoplasma gondii: an increasing priority for collaborative research?","volume":"9","author":"Innes","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"B29","doi-asserted-by":"publisher","first-page":"6222","DOI":"10.1128\/IAI.71.11.6222-6228.2003","article-title":"The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis.","volume":"71","author":"Ismael","year":"2003","journal-title":"Infect. Immun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0065-308X(08)60331-0","article-title":"The prevalence and source of Toxoplasma infection in the environment.","volume":"28","author":"Jackson","year":"1989","journal-title":"Adv. Parasitol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1550-7408.1983.tb02929.x","article-title":"Monoclonal antibodies to Toxoplasma cell membrane surface antigens protect mice from toxoplasmosis.","volume":"30","author":"Johnson","year":"1983","journal-title":"J. Protozool."},{"key":"B32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1128\/IAI.70.1.185-191.2002","article-title":"Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice.","volume":"70","author":"Johnson","year":"2002","journal-title":"Infect. Immun."},{"key":"B33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-4684-8326-0_6","article-title":"Destructive interactions between murine macrophages, tumor cells, and antibodies of the IgG2a isotype","author":"Johnson","year":"1985","journal-title":"Mechanisms of Cell-Mediated Cytotoxicity II"},{"key":"B34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations.","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"key":"B35","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1586\/erv.09.27","article-title":"Current status of toxoplasmosis vaccine development.","volume":"8","author":"Kur","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"B36","doi-asserted-by":"publisher","first-page":"6915","DOI":"10.1128\/IAI.71.12.6915-6920.2003","article-title":"Th1-directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae type 3.","volume":"71","author":"Lefeber","year":"2003","journal-title":"Infect. Immun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.184.2.597","article-title":"Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii.","volume":"184","author":"Liesenfeld","year":"1996","journal-title":"J. Exp. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00436-009-1393-1","article-title":"Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice.","volume":"105","author":"Liu","year":"2009","journal-title":"Parasitol. Res."},{"key":"B39","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CDLI.11.4.704-710.2004","article-title":"Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis.","volume":"11","author":"Martin","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"B40","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.4049\/jimmunol.142.9.3247","article-title":"Immune responses associated with early survival after peroral infection with Toxoplasma gondii.","volume":"142","author":"McLeod","year":"1989","journal-title":"J. Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis.","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.3347\/kjp.2009.47.S.S29","article-title":"GRA proteins of Toxoplasma gondii: maintenance of host-parasite interactions across the parasitophorous vacuolar membrane.","volume":"47(Suppl.)","author":"Nam","year":"2009","journal-title":"Korean J. Parasitol."},{"key":"B43","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1128\/IAI.65.5.1675-1682.1997","article-title":"Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii.","volume":"65","author":"Neyer","year":"1997","journal-title":"Infect. Immun."},{"key":"B44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1365-2249.1991.tb08150.x","article-title":"CD8+ T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice.","volume":"84","author":"Parker","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1084\/jem.158.4.1092","article-title":"Immune interferon induces the receptor for monomeric IgG1 on human monocytic and myeloid cells.","volume":"158","author":"Perussia","year":"1983","journal-title":"J. Exp. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/S0264-410X(98)00039-5","article-title":"Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii.","volume":"16","author":"Petersen","year":"1998","journal-title":"Vaccine"},{"key":"B47","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1073\/pnas.81.3.908","article-title":"Interferon-gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan.","volume":"81","author":"Pfefferkorn","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1089\/jir.1986.6.267","article-title":"Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts.","volume":"6","author":"Pfefferkorn","year":"1986","journal-title":"J. Interferon Res."},{"key":"B49","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/IAI.64.3.897-904.1996","article-title":"Different roles for interleukin-4 during the course of Toxoplasma gondii infection.","volume":"64","author":"Roberts","year":"1996","journal-title":"Infect. Immun."},{"key":"B50","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1128\/IAI.31.2.524-529.1981","article-title":"Trypanosoma cruzi infection in B-cell-deficient rats.","volume":"31","author":"Rodriguez","year":"1981","journal-title":"Infect. Immun."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1128\/IAI.68.3.1026-1033.2000","article-title":"B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii.","volume":"68","author":"Sayles","year":"2000","journal-title":"Infect. Immun."},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.1016\/B978-012369542-0\/50026-X","article-title":"Vaccination against toxoplasmosis: current status and future prospects","author":"Schaap","year":"2007","journal-title":"Toxoplasma gondii"},{"key":"B53","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1128\/IAI.71.1.309-316.2003","article-title":"A GRA1 DNA vaccine primes cytolytic CD8+ T cells to control acute Toxoplasma gondii infection.","volume":"71","author":"Scorza","year":"2003","journal-title":"Infect. Immun."},{"key":"B54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0923-2494(05)80095-1","article-title":"Macrophage interactions in toxoplasmosis.","volume":"144","author":"Sibley","year":"1993","journal-title":"Res. Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jconrel.2009.08.023","article-title":"Strong antibody responses induced by protein antigens conjugated onto the surface of lecithin-based nanoparticles.","volume":"141","author":"Sloat","year":"2010","journal-title":"J. Control. Release"},{"key":"B56","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.","volume":"236","author":"Snapper","year":"1987","journal-title":"Science"},{"key":"B57","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/ilar.46.3.280","article-title":"Adjuvants and antibody production: dispelling the myths associated with Freund\u2019s complete and other adjuvants.","volume":"46","author":"Stills","year":"2005","journal-title":"ILAR J."},{"issue":"429","key":"B58","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-429","article-title":"The extracellular matrix protein mindin as a novel adjuvant elicits stronger immune responses for rBAG1, rSRS4 and rSRS9 antigens of Toxoplasma gondii in BALB\/c mice.","volume":"14","author":"Sun","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"213","key":"B59","doi-asserted-by":"publisher","DOI":"10.1186\/1756-3305-4-213","article-title":"DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB\/c mice.","volume":"4","author":"Sun","year":"2011","journal-title":"Parasit. Vectors"},{"key":"B60","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.3128869","article-title":"Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.","volume":"240","author":"Suzuki","year":"1988","journal-title":"Science"},{"key":"B61","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.4049\/jimmunol.140.11.3943","article-title":"Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice.","volume":"140","author":"Suzuki","year":"1988","journal-title":"J. Immunol."},{"key":"B62","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1128\/IAI.65.11.4598-4605.1997","article-title":"Toxoplasma gondii sporozoites form a transient parasitophorous vacuole that is impermeable and contains only a subset of dense-granule proteins.","volume":"65","author":"Tilley","year":"1997","journal-title":"Infect. Immun."},{"key":"B63","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.4049\/jimmunol.117.5_Part_2.1999","article-title":"Immunity to Plasmodium berghei yoelii in mice. I. The course of infection in T cell and B cell deficient mice.","volume":"117","author":"Weinbaum","year":"1976","journal-title":"J. Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.parint.2008.05.001","article-title":"Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.","volume":"57","author":"Xue","year":"2008","journal-title":"Parasitol. Int."},{"key":"B65","doi-asserted-by":"publisher","first-page":"4578","DOI":"10.1016\/j.vaccine.2013.07.058","article-title":"The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.","volume":"31","author":"Zheng","year":"2013","journal-title":"Vaccine"},{"key":"B66","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00436-006-0341-6","article-title":"Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris.","volume":"100","author":"Zhou","year":"2007","journal-title":"Parasitol. Res."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T01:10:36Z","timestamp":1718500236000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fmicb.2016.00609\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,27]]},"references-count":66,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2016.00609","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,27]]}}}